These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10077182)

  • 41. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
    Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
    J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
    Giocos G; Kagee A; Swartz L
    AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Social and behavioral issues in phase III HIV preventive vaccine trials.
    Grinstead OA
    AIDS; 1995; 9 Suppl A():S245-50. PubMed ID: 8819592
    [No Abstract]   [Full Text] [Related]  

  • 44. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
    Belshe RB; Graham BS; Keefer MC; Gorse GJ; Wright P; Dolin R; Matthews T; Weinhold K; Bolognesi DP; Sposto R
    JAMA; 1994 Aug; 272(6):475-80. PubMed ID: 7913731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
    Karnasuta C; Paris RM; Cox JH; Nitayaphan S; Pitisuttithum P; Thongcharoen P; Brown AE; Gurunathan S; Tartaglia J; Heyward WL; McNeil JG; Birx DL; de Souza MS;
    Vaccine; 2005 Mar; 23(19):2522-9. PubMed ID: 15752839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Participation in two phase II prophylactic HIV vaccine trials in the UK.
    Gray K; Legg K; Sharp A; Mackie N; Olarinde F; De Souza C; Weber J; Peters B
    Vaccine; 2008 Jun; 26(23):2919-24. PubMed ID: 18450339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok.
    Thienkrua W; Todd CS; Chaikummao S; Sukwicha W; Yafant S; Tippanont N; Varangrat A; Khlaimanee P; Holtz TH
    AIDS Care; 2014; 26(11):1359-69. PubMed ID: 24797186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CDC international HIV prevention research activities among injection drug users in Thailand and Russia.
    Greenberg AE; Tappero J; Choopanya K; van Griensven F; Martin M; Vanichseni S; Santibanez S; Molotilov V; Hader S; Broyles LN
    J Urban Health; 2005 Sep; 82(3 Suppl 4):iv24-33. PubMed ID: 16107437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.
    Chesney MA; Chambers DB; Kahn JO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):266-71. PubMed ID: 9402073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-vaccine research and development in Thailand: evolution and challenges.
    Pitisuttithum P; Choopanya K; Rerk-Ngnam S
    Vaccine; 2010 May; 28 Suppl 2():B45-9. PubMed ID: 20510743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Foundations for a Phase III human immunodeficiency virus vaccine trial: A decade of Thai-U.S. Army collaborative research.
    Brown AE; Nitayaphan S
    Mil Med; 2004 Aug; 169(8):588-93. PubMed ID: 15379068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventive HIV vaccine development in Thailand.
    Nitayaphan S; Brown AE
    AIDS; 1998; 12 Suppl B():S155-61. PubMed ID: 9679641
    [No Abstract]   [Full Text] [Related]  

  • 53. A social vaccine? Social and structural contexts of HIV vaccine acceptability among most-at-risk populations in Thailand.
    Newman PA; Roungprakhon S; Tepjan S; Yim S; Walisser R
    Glob Public Health; 2012; 7(9):1009-24. PubMed ID: 22780324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa.
    Jaspan HB; Soka NF; Mathews C; Flisher AJ; Mark D; Middelkoop K; Wood R; Bekker LG
    Int J STD AIDS; 2010 Mar; 21(3):172-6. PubMed ID: 20215620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVE. AIDS Community Health Initiative Enroute to the Vaccine EFfort.
    Koblin BA; Taylor PE; Avrett S; Stevens CE
    AIDS; 1996 Nov; 10(13):1555-61. PubMed ID: 8931792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
    Agnew B
    Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
    [No Abstract]   [Full Text] [Related]  

  • 57. Large HIV vaccine trial begins.
    Santiago L
    GMHC Treat Issues; 1998 Oct; 12(10):1-5. PubMed ID: 11365900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of northern Thai factory workers as participants in HIV vaccine trials.
    Natpratan C; Nantakwang D; Beyrer C; Kunawararak P; Gunhom C; Celentano DD; Nelson KE; Khamboonruang C
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):457-62. PubMed ID: 9185253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania.
    Tarimo EA; Thorson A; Kohi TW; Bakari M; Sandstrom E; Mhalu F; Kulane A
    BMC Infect Dis; 2011 Oct; 11():283. PubMed ID: 22023776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.
    Gilbert PB; Chiu YL; Allen M; Lawrence DN; Chapdu C; Israel H; Holman D; Keefer MC; Wolff M; Frey SE;
    Vaccine; 2003 Jun; 21(21-22):2933-47. PubMed ID: 12798637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.